News

Fierce Pharma2d
AstraZeneca takes $181M hit in Syntimmune shareholder lawsuit on top of previous $130M award
For the second time in nine months, a Delaware judge has sided (PDF) with Syntimmune shareholders over AstraZeneca, granting ...
BioPharma Dive1d
AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans
AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...
AstraZeneca Unit Owes $180 Million-Plus in Syntimmune Case (1)
An AstraZeneca Plc affiliate suffered a greater than $180 million court loss Wednesday over its lackluster efforts to ...
Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk
Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...
STAT13d
AstraZeneca’s CEO balances cancer-fighting opportunities with political uncertainty
AstraZeneca CEO Pascal Soriot views the company's stock price — up just 10% year-to-date — as a marker of how he is doing. He ...
Keeping AstraZeneca's Edge in Oncology: Vanguards of Health Care
Understand every aspect of the global economy – and know how to make your next move.
Explore more
AstraZeneca PLC ADR outperforms market on strong trading day
AstraZeneca PLC ADR closed 14.46% short of its 52-week high of $87.68, which the company reached on August 30th.
VOV.VN1d
AstraZeneca encouraged to build pharmaceutical manufacturing plant in Vietnam
VOV.VN - Prime Minister Pham Minh Chinh has proposed that AstraZeneca consider building a pharmaceutical manufacturing plant ...